Brazil Point-of-Care Glucose Testing Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type, by Application, by End User : Opportunity Analysis and Industry Forecast, 2023-2032

The Brazil point-of-care glucose testing market is anticipated to witness substantial growth during the forecast period. This is attributed due to rise in prevalence of diabetes with both type 1 and type 2 diabetes. In addition, the increase in the number of people with obesity, unhealthy lifestyle, lack of physical activity, and poor dietary choices is expected to fuel the growth of the market.

 

Furthermore, rise in the awareness regarding the importance of diabetes screening and management among the Brazilian population is expected to drive the growth of the market. In addition, the government initiatives to promote early diagnosis and treatment of diabetes among people contribute toward the growth of the market. Moreover, the launch of advanced point-of-care devices, such as lancing devices & strips and blood glucose meters, is expected to augment the growth of the Brazil point-of-care glucose testing market. However, the high costs associated with these testing devices and limited reimbursement options restrain the market growth.  In addition, the lack of skilled personnel to carry out the glucose tests hamper the growth of the Brazil point-of-care glucose testing market. 

 
On the contrary, the Brazil point-of-care glucose testing market is expected to provide several opportunities for new players and future trends in the market. The increase in awareness regarding the importance of glucose testing among the population is one of the major trends driving the growth of the market. In addition, the government initiatives to promote people to get their blood sugar levels tested are expected to provide remunerative opportunities for the growth of the market. Furthermore, the introduction of more advanced and efficient testing devices is another trend which is expected to provide lucrative opportunities for the growth of the market. 
 
In addition, the government initiatives to promote point-of-care glucose testing devices that are more affordable and accessible are expected to provide new avenues for the growth of the market. 

 

The key regulation governing the use and aimed at ensuring the safety and efficacy of the point-of-care glucose testing devices in Brazil include the National Health Surveillance Agency (ANVISA), Brazil National Council of Health (CNS), and Brazilian Health Regulatory Agency (ANVISA).  

 The Brazil point-of-care glucose testing market is segmented into product type, application, and end user. On the basis of product type, the market is classified into lancing devices & strips and blood glucose meter. By application, the market divided into type 1 diabetes and type 2 diabetes. Depending on the end user, the market is segregated into hospitals and clinics, home care settings, and others. 
  
The Brazil point-of-care glucose testing market is expected to witness significant growth across all the regions in the country, such as the South, North, and Central regions. The South region is expected to hold a larger share of the market due to the increase in the prevalence of diabetes in the region. This is mainly due to the high consumption of junk food and inactive lifestyle in the region. 

 

In addition, the North and Central regions are expected to witness considerable growth in the upcoming years. This is attributed due to the presence of high population density and rise in awareness regarding the importance of diabetes screening and management. Furthermore, the government initiatives to promote point-of-care glucose testing devices that are more affordable and accessible in the region are anticipated to provide impetus to market growth. 
  
The key players operating in the Brazil point-of-care glucose testing market are Abbott, Ascensia Diabetes Care, Roche, LifeScan, Medtronic, Terumo Corporation, Bayer AG, Arkray, Accu-Chek, and Trividia Health. These companies have adopted several strategies such as new product launches, acquisitions, business expansions, partnerships, and investment opportunities in the last four years to stay ahead in the market. 
 
For instance, in 2019, Roche launched its new Accu-Chek Formulate portfolio, which includes a range of blood glucose monitoring systems, diabetes management software, and glucose monitoring accessories. Abbot Laboratories launched the Afinion 2 Analyzer, which is a highly advanced point-of-care analyzer that helps physicians to detect a range of diseases at the point-of-care. 
 
Several new companies are identified as emerging in the market, such as Abbott, Ascensia Diabetes Care, Roche, LifeScan, Medtronic, Terumo Corporation, Bayer AG, Arkray, Accu-Chek, and Trividia Health. 

  Key Benefits For Stakeholders

• Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.
• Analyze the key strategies adopted by major market players in Brazil point-of-care glucose testing market.
• Assess and rank the top factors that are expected to affect the growth of Brazil point-of-care glucose testing market.
• Top Player positioning provides a clear understanding of the present position of market players.
• Detailed analysis of the Brazil point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.
• Identify key investment pockets for various offerings in the market.

  Brazil Point-of-Care Glucose Testing Market Report Highlights